Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iopamidol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Iopamidol 61.2% s/f suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 150mg(I)/mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 200mg(I)/mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 300mg(I)/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 340mg(I)/mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 370mg(I)/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 200mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 300mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 370mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 250mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg/mL + iodine 200mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg/mL + iodine 200mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg/mL + iodine 200mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg/mL + iodine 200mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg/mL + iodine 200mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 150mg(I)/mL injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 150mg(I)/mL injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 150mg(I)/mL injection solution 30 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 150mg(I)/mL injection solution 50 mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 200mg(I)/mL injection solution 50 mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 200mg(I)/mL injection solution 30 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 200mg(I)/mL injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 200mg(I)/mL injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 300mg(I)/mL injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 300mg(I)/mL injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 300mg(I)/mL injection solution 30 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 300mg(I)/mL injection solution 50 mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 340mg(I)/mL injection solution 50 mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 340mg(I)/mL injection solution 30 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 340mg(I)/mL injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 340mg(I)/mL injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 370mg(I)/mL injection solution 10 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 370mg(I)/mL injection solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 370mg(I)/mL injection solution 30 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 370mg(I)/mL injection solution 50 mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 61.2% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only iopamidol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely iodine (as iopamidol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Iopamidol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only iopamidol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely iodine (as iopamidol) 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Iodine (as iopamidol) 370 mg/mL solution for injection |
Has precise active ingredient |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely iodine (as iopamidol) 340 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Iopamidol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |